UPXI - UPEXI, INC.
0.9623
-0.118 -12.231%
Share volume: 8,464,857
Last Updated: 03-05-2026
Pharmaceutical Products/Medicinal Chemicals:
2.23%
PREVIOUS CLOSE
CHG
CHG%
$1.08
-0.12
-0.11%
View ratios
| Fiscal Date | 09-30-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 11-20-2023 | 07-09-2024 | 01-07-2025 | 12-19-2024 | 02-14-2025 | 05-16-2025 | 11-12-2025 | 02-10-2026 | |
| Total revenue | 27.348 M | 14.445 M | -37.620 M | 4.357 M | 4.005 M | 3.160 M | 9.240 M | 8.052 M | |
| Cost of revenue | 18.640 M | 11.562 M | -30.582 M | 1.426 M | 1.031 M | 1.601 M | 956.745 K | 1.341 M | |
| Gross profit | 8.708 M | 2.883 M | -7.038 M | 2.930 M | 2.974 M | 1.559 M | 8.283 M | 6.711 M | |
| -66.89% | -344.10% | 141.63% | 1.50% | -47.58% | 431.27% | -18.98% | |||
| Operating expenses | 5.105 M | 2.399 M | -186.598 K | 1.368 M | 1.549 M | 2.643 M | 9.257 M | 5.523 M | |
| Selling general and admin | 5.105 M | 2.399 M | -186.598 K | 1.368 M | 1.549 M | 2.643 M | 9.257 M | 5.523 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 28.490 M | 7.820 M | 5.529 M | 4.265 M | 4.047 M | 5.146 M | -60.872 M | 182.076 M | |
| -72.55% | -29.29% | -22.86% | -5.11% | 27.15% | -1,282.83% | 399.11% | |||
| Operating income | -1.142 M | -4.937 M | -14.596 M | -1.335 M | -1.073 M | -3.587 M | 69.155 M | -175.365 M | |
| Ebit | -1.142 M | -4.937 M | -17.357 M | -1.335 M | -1.073 M | -3.587 M | 69.155 M | -175.320 M | |
| Pretax income | -1.829 M | -5.599 M | -15.784 M | -1.626 M | -1.301 M | -3.832 M | 66.748 M | -178.925 M | |
| 206.16% | 181.91% | -89.70% | -19.95% | 194.45% | -1,842.02% | -368.06% | |||
| Income tax | -472.367 K | 1.502 M | -2.337 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -1.356 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 100.00% | |||||||||
| Net income | -1.356 M | -5.798 M | -13.562 M | -1.626 M | -1.301 M | -3.832 M | 66.748 M | -178.925 M | |
| -327.46% | -133.91% | 88.01% | 19.95% | -194.45% | 1,842.02% | -368.06% |